Skip to main content
Per Eystein Lønning on Muck Rack

Per Eystein Lønning

As seen in: Wiley Online Library, BioRxiv, Dagbladet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Per Eystein

Contact Per Eystein, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.

|
By Per Eystein Lønning, Oleksii Nikolaienko, Stian Knappskog
| Wiley Online Library Verified
Corresponding Author Per Eystein Lønning Department of Oncology, Haukeland University Hospital, Bergen, Norway Correspondence Per Eystein Lønning, Department of Oncology, Haukeland University Hospital, Jonas Lies vei 65, N5021, Bergen, Norway.
Open in Who Shared Issue with article?

Minneord om Hans Petter Eikesdal

|
By Oddbjørn Straume, Stian Knappskog, Per Eystein Lønning, Olav Dahl
| Dagbladet Verified
Torsdag 6 juli 2023 var en fin sommerferiedag på Vestlandet. Så, om kvelden kom telefonen; «Hans Petter er død». Alt kollapser på et øyeblikk. Så brutalt. Så meningsløst. Så skjørt kan livet være. Hans Petter døde i en bilulykke ved Sandnes, på vei til «landet», hytta ved Skjoldastraumen, hans fristed. Vi ønsker å minnes Hans Petter, hans betydning for kreftforskningen og hans dessverre ufullendte livsverk.
Open in Who Shared Issue with article?

epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data

|
By Oleksii Nikolaienko, Per Eystein Lønning, Stian Knappskog
| BioRxiv
New Results doi: https://doi.org/10.1101/2022.06.30.498213 Abstract Low-level mosaic methylation of the BRCA1 gene promoter occurs in 5–8% of healthy individuals and is associated with a significantly elevated risk of breast and ovarian cancer. Similar events may also affect other tumour suppressor genes, potentially being a significant contributor to cancer burden.
Open in Who Shared Issue with article?
See all 6 articles